With cutting-edge science, our teams of scientists first understand the inner workings of a disease. They might design, develop and screen thousands of compounds or generate hundreds of antibodies to several promising lead candidates.
Before clinical trials can begin, teams must scale-up production to ensure an adequate supply of the investigation candidate so as to provide sufficient evidence of safety and effectiveness.
Medical advances can only be realized through the clinical trial process. It helps determine whether investigational vaccines, medicines, or new uses for existing medicines are safe and effective.
Submission to relevant regulatory agencies for approval is required before a therapeutic or vaccine can be marketed. Our R&D role continues well after a new medicine or vaccine is approved, where we conduct ongoing monitoring and evaluate the safety, effectiveness and value of our products.